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During an attempt to  explore the mechanism of cobalt and vitamin B,, effect on the 
peroxidase and tyrosine iodinase activity, it was observed that cobalt and not vitamin B,, 
in vivo elicits a high plasma titer of a humoral factor, erythropoietin, which caused increased 
69Fe incorporation into red blood corpuscles. This erythropoietin was extracted from plasma or 
kidney and partially purified. This partially purified erythopoietin preparation when injected 
into starved rat caused increased 69Fe incorporation into red blood corpuscles. The potency of 
the partially purified erythropoietin preparation from plasma and kidney was compared. This 
partially purified erythropoietin, as well as sheep step-I erythropoietin, when administered to  
mice gave rise to a response almost similar to cobalt administration. It appears that the effect 
of cobalt on the peroxidase or tyrosine iodinase activity might be mediated through the elevation 
of the erythropoietin titer of plasma. Moreover, this erythropoietin was found to  stimulate both 
peroxidase and tyrosine iodinase activity of the enzyme preparation of submaxillary gland in 
experiments in vitro. Erythropoietin, purified further in our laboratory, also produced the same 
effect. Neuraminidase-treated erythropoietin, in contrast, failed to execute any such stimulatory 
effect on the iodination of tyrosine. 
Recently, it has been reported from our laboratory 
[l] that GoZ+ or vitamin B,, in vivo stimulates the 
peroxidase activity of mouse thyroid and submaxil- 
lary glands. The tyrosine iodinating enzyme activity 
of both the glands is also stimulated by vitamin B,, 
in vivo. Studies in vitro indicated that only Coz+ 
has a direct inhibitory effect on the enzymatic in- 
corporation of iodide by the thyroid gland while 
cobamide coenzyme has a direct stimulatory role on 
the same process of the submaxillary gland. It was 
suggested that the effect of Go2+ or vitamin B,, 
in vivo may be mediated, a t  least partially, through 
the cobamide coenzyme [I]. 
However, as these effects of Co2+ or vitamin B,, 
on these enzymes cannot be fully explained by 
mediation only through the cobamide coenzyme, 
some other mechanism was therefore looked for. 
Survey of the literature points out that Co2+ also 
stimulates erythropoiesis [2,3]. It is now clear that 
this effect of Co2+ is mediated not through vitamin 
B,, coenzyme but through the elaboration of a high 
level of erythropoietin in plasma [4] which is in- 
volved in the differentiation of red blood corpuscles 
along with hemogIobin biosynthesis [5]. The same 
Enzymes. Peroxidase (EC 1.11.1.7); neuraminidase 
(EC 3.2.1.18). 
observation has also been confirmed demonstrating 
that Go2+ and not vitamin B,, resulted in the eleva- 
tion of the level of plasma erythropoietin. The extrac- 
tion and partial purification of this erythropoietin 
from plasma or kidney of cobalt-treated mice and 
studies of its potency have been presented. Finally 
the results on the effect of this partially purified ery- 
thropoietin as well as the erythropoietin from other 
sources on the iodinating enzyme system of mouse 
thyroid and submaxillary glands are reported in the 
present communication. 
MATERIALS AND METHODS 
Male Swiss mice of average body weight 25g 
were used throughout the experiments. Na1311, 
WoC1, and 6aFeC1, were obtained from Bhabha 
Atomic Research Centre, India. Sheep plasma 
step I erythropoietin (0.4 U/mg) was purchased 
from Connaught Medical Research Laboratory (Uni- 
versity of Toronto, Canada) and human urinary 
erythropoietin (2.6 Ujmg) was obtained through the 
courtesy of Dr J. M. Stengle (N.I.H., Bethesda). 
DEAE-cellulose and neuraminidase (type V) were 
procured from Sigma Chemical Co. Amidoschwarz 
and n-butanone were obtained from E.Merck. All 
other materials used were of reagent grade. 
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Assay of Erythropoietin 
by s9Fe Incorporation study 
The erythropoietic activity of Coa+ or vitamin 
B,, was determined by studying the SsFe incorpora- 
tion into red blood corpuscles. Co2+ (O.OMyg/g) or 
vitamin B,, (0.5 pg/g) was daily injected separately 
into a group of mice for six or three days respectively. 
On the last day of injection, 1.OpCi of 69FeCl, in 
0.2 ml 0.90/, saline was injected intraperitoneally. 
Blood was then drawn a t  different time intervals 
after 59Fe administration and collected in a test tube 
containing a few milligrams of sodium citrate as an 
anticoagulant. Radioactivity of an aliquot of this 
blood was measured in a solid scintillation y-ray 
spectrometer. 69Fe incorporation into red blood 
corpuscles was then calculated assuming the blood 
volume to be 7 O / / ,  body weight. 
Erythropoietin, after partial purification from 
plasma or kidney, was assayed by studying the 69Fe 
incorporation into red blood corpuscles of starved 
rat according to the method of Fried et al. [6]. 
Male rats weighing 100-150g were used for the 
assay. Rats were starved for 30h and grouped as 
control and experimental, each group containing a t  
least three animals. The control group was injected 
subcutaneously with 0.5 ml of the erythropoietin 
preparation obtained from plasma or kidney of 
normal animals, while the experimental group 
received 0.5 ml of the same from plasma or kidney of 
Co2+-treated mice. 16 h later, 1.0 yCi 69FeC1, in 0.9O/, 
saline (0.2 ml) was injected intraperitoneally to each 
animal and blood was collected from the heart 18 h 
after 69Fe injection. 0.1 ml of the blood was then taken 
on a planchet, spread uniformly, dried in air and 
finally the radioactivity was measured in a solid 
scintillation p r a y  spectrometer. The percentage of 
59Fe incorporated into red blood corpuscles was 
calculated assuming the blood volume as 5 O / ,  (and 
not 7 0 / ,  as in case of mouse). 
Extractim of Erythropoietin 
from Plasma OT Kidney 
Co2+ a t  a dose of 0.044 to  0.1 pg/g body weight 
stimulates the peroxidase activity, the stimulation 
being maximum after six days of administration [l]. 
Hence approximately 2.0 pg Coa+ per mouse was in- 
jected intramuscularly for six days in a group of 
mice containing not less than six animals. 16 h after 
the last injection, they were ether-anaesthetised and 
blood was drawn from the heart and collected as 
before. The kidneys of each mouse were also taken 
out a t  the same time. 
Extraction from Plasma 
Erythropoietin was extracted from plasma ac- 
cording to the method of Borsook et al. [7].  The ex- 
traction was carried out in parallel from the blood 
of normal as well as Co2+-treated mice. Blood (10 ml 
from six animals) was centrifuged a t  2000 rev./min 
for 15 min and the plasma was collected. The plasma 
was acidified with 0.1 N HCl to bring down the pH 
to 5.5. This acidified plasma was then heated to 
80 "C for 10 min and centrifuged to collect the super- 
natant. The coagulum was washed with distilled water, 
heated as before, centrifuged and the supernatants 
were combined. The process was repeated once more 
and finally the combined supernatant was dialysed 
overnight against one liter of distilled water to remove 
dialysable Co2+, if any. The straw-coloured dialysed 
material was cloudy in appearance and the colour 
was more intense in the case of the plasma of Co2+- 
treated mice. This was then lyophilised and the 
volume was finally made up to the original volume 
of the plasma with distilled water. This preparation 
was then assayed for erythropoietin as described 
earlier. 
Extraction from Kidney 
Preliminary extraction of erythropoietin from 
kidney was carried out according to the method of 
Contrera et al. [8]. The normal as well as Co,+-treated 
kidneys were extracted simultaneously. The kidneys 
(3 g from six mice) were cut into pieces and homo- 
genised in 6 ml 0.02 M hypotonic phosphate buffer 
p R  6.8 to  get a 50°/, homogenate. The homogenate 
was then centrifuged a t  37000 x g for 30 min in a 
Sorvall RC-ZB refrigerated centrifuge and the super- 
natant was collected. This supernatant was then 
dialysed overnight against one liter of 0.9O/, NaCl 
solution and assayed for erythropoietin by 59Fe in- 
corporation study as described before. 
Potency of the Preparations 
The potency of the partially purified erythro- 
poietin was determined from a standard curve of 
W e  incorporation (Fig. 1) using sheep erythropoietin 
as a standard. The assay procedure was the same as 
already described. The potency was expressed as 
U/mg protein. 
Effect of Erythropoietin 
on the Peroxidase and Tyrosine-Iodinase Activity 
For the assay of peroxidase and tyrosine iodinat- 
ing enzyme activity of mouse thyroid and submaxil- 
lary glands, 0.4 unit of the extracted erythropoietin 
preparation or sheep erythropoietin was daily inject- 
ed subcutaneously for six days. 16 h after the last 
injection, the animals were sacrsced and the enzyme 
was prepared from the thyroid or submaxillary 
gland and assayed as described earlier [ 11. Peroxidase 
activity was also assayed by measuring the formation 
of triiodide [9]. The incubation mixture contained 
in a final volume of 3 ml: 150 pmol acetate buffer 
pH 5.0 for thyroid and 4.6 for submaxillary enzyme 
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preparation, 1 pmol KI, 2 pmol H,O, for thyroid 
and 500 nmol for submaxillary enzyme, enzyme 
preparation of a suitable volume and water. The 
increase of absorbance was measured for 1 min a t  an 
interval of 10 s a t  353 nm to measure the triiodide 
(I3-) formation. For study in vitro, sheep or human 
erythropoietin was added in the incubation mixture 
as described in the legends of figures or tables. 
Purification of Erythropoietin on DEAE-Cellulose 
Sheep erythropoietin (step I), purchased from 
Connaught Medical Research Laboratory was fur- 
ther purified according to the method of White et al. 
[ 101. Erythropoietin, equilibrated against 0.0375 M 
NaCl pH 4.5, was applied on a DEAE-cellulose 
column (9 cm x 1 cm) equilibrated with the above- 
mentioned solution. Gradient elution was carried out 
using 1.0 M NaCl in the reservoir and 100 m10.025 M 
NaCl in the mixing chamber. Fractions of 3.0ml 
were collected in each tube. 
Protein Estimation 
Protein was determined according to the method 
of Lowry et al. [Ill using bovine serum albumin as 
standard. 
RESULTS 
The role of Co2+ or vitamin B,, on the erythro- 
poietin titer of mouse plasma is presented in Table 1. 
The result shows that Co2+ treatment produced 
about a three-fold increase in 59Fe incorporation 
over the normal, whereas, vitamin B,, administra- 
tion did not cause much change suggesting that 
vitamin B,, had no effect on the erythropoietin 
synthesis in normal animals. The effect of Coa+ on 
the 5gFe incorporation may be due to  increased ery- 
thropoietin synthesis or its direct effect on the mar- 
row erythropoiesis as shown by Fisher [12] in isolat'ed 
perfused hind legs of dogs. However sgFe incorpora- 
tion is routinely used for the bioassay of erythro- 
poietin [6--8,13-191. The result also shows that 
69Fe incorporation reached a steady level, 18 h after 
59Fe injection while the 4-h value was quite high, 
possibly due to the presence of non-incorporated 
69Fe which eventually got excreted within 18 h. 
Since the above experiment indicates that the 
role of Co2f is to  elevate the erythropoietin level of 
plasma, attempts were made to isolate this erythro- 
poietin from plasma as well as from kidney, which is 
the site of production of erythropoietin. The partially 
purified preparation from plasma or kidney had the 
ability to increase the 69Fe incorporation significantly 
over the control value as shown in Table 2. Table 2 
also shows that the kidney erythropoietin preparation 
stimulated 5%Fe incorporation by about 5001, more 
than plasma erythropoietin. However, when the 
Table 1. The effect of Go2+ or vitamin BIZ on the erythropoietin 
level of plasnul of normal mice 
2 pg Go2+ or 12 pg vitamin BIZ per mouse was injected for 
six or three days respectively. The percentage 59Fe incorpo- 
rated was calculated assuming the blood volume of the mouse 
as 7O/ ,  body weight. The results represent the mean value of 
two sets of experiments containing at least six animals in 
each group 
Amount of L'Fe incorporated into red blood 
corpuscles after Treatment 
4 h  18 h 24 h 
"/. 10 "lo 
None 21 8 9 
Co=+ 25 27 26 
Vitamin B,, 28 12 10 
Table 2. The effect of partially purified erythropoietin on the 
S@Fe incorporation into red blood corpuscles of starved rats 
Extraction of erythropoietin from normal as well as Co2+- 
injected mouse plasma or kidney was carried out as men- 
tioned under Materials and Methods. Potency was determined 
from the standard curve using sheep plasma erythropoietin 
as standard. The results of the 59Fe incorporation represent 
the mean value of three sets of experiments containing three 
animals in each group. The percentage 59Fe incorporated 
was calculated assuming the blood volume as 50/, body weight 
of rat 
Preparation incor- Control- Protein porated corroctcd injected Potency 
vn.111e 
"1. mg U/mg 
None (saline) 16 
Normal plasma 16 
Cobalt-treated 
Normal kidney 16 
Cobalt-treated 
plasmas 31 15 0.6 1.6 
kidney& 39 23 2.2 0.7 
The dose-response curves of these preparations were found to be 
parallel to the standard dose-response curve (Fig. 1). 
potency was calculated from the standard curve as 
shown in Fig. 1, the plasma erythropoietin was found 
to  have a potency almost double that of the kidney 
erythropoietin (Table 2). This may be due to  conti- 
nuous production and release of erythropoietin from 
the kidney to the blood. The preparation obtained 
from normal plasma or kidney when tested for ery- 
thropoietin, revealed no further increase of 59Fe 
incorporation over the saline-injected control value 
and this may be due to the fact that the starved rat 
assay is not sensitive enough to  account for the 
normal concentration of erythropoietin present in 
blood or kidney. 
The effect of this partially purified erythropoietin 
on the peroxidase activity is presented in Table 3, 
which shows that the peroxidase activity of both the 
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Table 3. Effect in vivo of partially purified erythropoietin im the perozidase activity 
Erythropoietin was partially purified from plasma or kidney extract of normal or Coz+-treated mice and injected into freash 
mice for this experiment. 0.4 U erythropoietin extracted from Co2+-treated mice was injected for 6 days. Peroxidase activity 
was measured by the procedure as described earlier [l]. All values are mean + S.E. 
Source of erythropoietin 
~ 
Peroxidase activity with 
Guaiacol o-Dianisidine 
Thyroid Submaxillary Thyroid Submaxillary 
min-'x mg-' min-' x mg-l 
0.15 f 0.008 0.25 f 0.02 0.27 f 0.02 Plasma of normal animal 
Plasma of Co2+-treated animal 0.50 f 0.07 0.21 * 0.021 0.42 f 0.05 0.55 f 0.01 
Kidney of normal animal 0.25 f 0.02 0.12 f 0.011 0.20 f 0.01 0.25 & 0.05 
Kidney of Co2+-treated animal 0.47 & 0.08 0.21 f 0.034 0.46 f 0.08 0.56 & 0.07 
P < 0.01 P < 0.02 P < 0.05 P < 0.001 
0.30 f 0.03 
P < 0.02 P <  0.05 P < 0.05 P < 0.05 
30, I 
2 5 t  
." - 1  20 / 
0 
0 0.4 0.8 1 .2 1.6 
Erythropoietin (U/ mg) 
Table 4. Effect in vivo of partialZy purified erythropietin on 
the tyrosine i o d i w e  activity 
Experimental conditions were same as mentioned in Table 3. 
The preparation and assay of the enzyme was reported 
earlier [l]. For the assay of tyrosine iodinase activity of the 
thyroid microsomal preparation, the incubation mixture 
contained in a final volume of 3 ml:300 ymol phosphab 
buffer pH 7.4, 40 nmol KI, 20 pCi Na%C, 4 pmol L-tyrosine, 
2 pmol glucose, 250 yg glucose oxidase, 8 pg of enzyme 
preparation and water. In  case of submaxillary gland, the 
incubation mixture contained the same except that 300 ymol 
phosphate buffer pH 6.5 and 250 pg soluble supernatant 
protein was used as the enzyme preparation. The tyrosine 
iodinase activity was measured as I- incorporated in nmol 
x min-lx mg-I. All values are mean f S.E. 
Tyrosine iodinase activity 
Source of erythropoietin __ 
Thyroid Submaxillary 
nmol x Inin-' x mg-I 
16 f 2.6 Fig. 1. Standard curve of sheep plasma erythropoietin. The of normal animal 9.0 o.5 assay of erythropoietin by 58Fe incorporation study was 
5.5 f 0.3 24 f 3.0 described under Materials and Methods. Values given in 
P < 0.02 P < 0.05 the figure were corrected for the 16O/, 59Fe incorporation value of normal animals. The data presented is the mean 
value of two sets of experiments containing a t  least three Kidney of normal animal 9.5 0.6 16 f 1.5 
animals in each group 
animal 6.8 f 0.4 23.4 f 2.8 
P < 0.02 
Plasma of Co2f-treated 
animal 
Kidney of Co2+-treated 
P < 0.02 
thyroid and submaxillary glands was significantly 
stimulated in vivo by this partially purified erythro- 
poietin preparation. The tyrosine iodinase activity 
(Table 4) of the thyroid gland was inhibited to some 
extent while that of the submaxillary gland was 
significantly stimulated under the same condition. 
The effect of partially purified erythropoietin 
from the Co2+-treated mice on the above enzyme 
system tempted us to investigate whether prepara- 
tions of erythropoietin from other sources could 
produce the same effect. Table 5 presents the effect 
in vivo of sheep plasma erythropoietin on the per- 
oxidase activity of the thyroid and submaxillary 
glands. The result shows that erythropoietin sig- 
nificantly stimulated the peroxidase activity. Results 
with guaiacol and KI peroxidation suggest that the 
peroxidase, which we measured in these experiments, 
was a true peroxidase. 
The activity of tyrosine iodinase was also in- 
vestigated after erythropoietin administration. The 
result in Table 6 indicates that sheep erythropoietin 
in vivo inhibited the thyroid iodinase activity by 
50°/, while it stimulated that of the submaxillary 
gland by 88O/, under identical condition. 
The stimulation of peroxidase and tyrosine iodin- 
ase activity of the submaxillary gland by erythro- 
poietin in vivo led us to  investigate whether erythro- 
poietin has any effect in vitro on these two enzymes 
activities. While studying its effect on peroxidase 
activity by o-dianisidine peroxidation, it was found 
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Table 5. The effect in vivo of erythropoietin on the peroxidme activity 
0.4 unit of sheep erythropoietin was injected for 6 days. The preparation and assay of the enzyme activity were described under 
Materials and Methods. The peroxidase activity was measured as the change in absorbance x min-l x mg-l. All values are 
mean f S.E. 
Peroxidase activity 
Treatment Guaiacol o-Dianisidine KI 
Thyroid Submaxillary Thyroid Submaxillary Thyroid Submaxillary 
min-I x m g '  min-I x mg-' min-1 x mg-' 
None 0.23 f 0.01 0.14 f 0.03 0.25 f 0.10 0.17 5 0.011 0.20 f 0.02 0.47 & 0.2 
Erythropoietin 0.88 & 0.05 0.46 f 0.01 0.44 f 0.03 0.46 f 0.098 0.42 f 0.07 1.60 f 0.61 
P < 0.02 P < 0.05 P < 0.05 P < 0.01 P < 0.05 P < 0.01 
Table 6. The effect in vivo of erythropoietin on tyrosine 
wdinase activity 
0.4 unit of sheep erythropoietin was injected for 6 days. 
The assay system was same as described in the legend of 
Table 4. The tyrosine iodinase activity was measured as the 
amount of I- incorporated in nmol x min-l x mg-l. All values 
are mean & S.E. 
Tyrosine iodinase activity 
Treatment 
Thyroid Submaxillary 
nmol x min-' x mg-' 
None 9.00 f 0.50 16 f 1.3 
Er ythropoietin 4.50 & 0.40 30 5 3.6 
P < 0.05 P < 0.05 
Table 7 .  Effect of erythropoietin in vitro on the peroxidme 
E represents enzyme preparation from submaxillary gland 
and Ep represents sheep erythropoietin. Assay of peroxidase 
activity was the same as described under Materials and Me- 
thods except that different concentration of erythropoietin 
was added before the addition of enzyme. The result is a 
typical one and verified in a t  least three experiments 
activity 
Peroxidase activity 
Conc of sheep 
erythropoietin ~ ~ i ~ ~ ~ l  assay I.- asmy 
(in 3 ml) 
E (1) EP (2) E +ED (3) E (1) EP (2) E+ Ep(3) 
unit min-' min-' 
0 0.046 - 0.046 0.10 - 0.10 
0.04 0.002 0.056 0.002 0.14 
0.08 0.004 0.077 0.005 0.15 
0.16 0.010 0.090 0.006 0.16 
that erythropoietin itself showed a strong pseudo- 
peroxidase activity as evidenced by its significant 
nonenzymatic peroxidation of o-dianisidine. Hence 
peroxidase activity was finally measured using gua- 
iacaol which is least sensitive to pseudoperoxidases 
and also using KI to measure the iodide peroxidase 
activity. Table 7 shows that erythropoietin still 
demonstrated a negligbile peroxidase activity to- 
wards guaiacol or KI peroxidation. However, at  
any particular concentration of erythropoietin, the 
peroxidase activity (column 3) was found to be grea- 
I 
T I I I 
0 0.04 0.08 0.12 0.16 
Erythropoietin concn. (unit /3rnl) 
Fig.2. Effect of ey thropie t in  in vitro on the iodination of 
tyrosine by s u b m i l l a r y  enzyme. The incubation mixture 
contained the same as described in the legend of Table4. 
Erythropoietin of different concentration was added to the 
incubation mixture. The result is a typical one and verified 
in at least five experiments 
ter than the additive peroxidase activities of either 
enyzme alone (column 1) or erythropoietin alone 
(column 2). Almost similar results were obtained in 
the case of I,- assay in the presence of erythropoie- 
tin. Fig. 2 demonstrates that the iodination reaction 
catalysed by the submaxillary supernatant enzyme 
preparation was also stimulated in vitro by sheep 
erythropoietin. The stimulation increased up to the 
concentration of 0.04 unit and thereafter the stimula- 
tion decreased. However, erythropoietin even up to 
a concentration of 0.16 unit did not increase the non- 
enzymatic iodination of tyrosine. Human urinary 
erythropoietin which is more purified and potent 
(2.6 U/mg) preparation, when added in. vitro, also 
stimulated the iodination of tyrosine by the same 
enzyme preparation in a similar manner. 
That this stimubtory effect on iodination reac- 
tion is due to erythropoietin and not due to other 
contaminants, is strengthened by the observation 
shown in Table 8. The result shows that when ery- 
thropoietin, being a glycoprotein, is treated with 
neuraminidase, dialysed overnight and added to the 
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Tables. Effect of neurarninidase on the stirnulatory effect of 
erythropoietin on tyrosine iodination 
The assay system for the submaxillary enzyme was described 
in the legend of Table 4. I n  the experiment 3, 600pg ery- 
thropoietin was incubated with 50 pg neuraminidase at 
37 "C in 0.2ml 0.05M acetate buffer pH5.0 for 30min. 
The whole mixture was made up to  0.5 ml with distilled 
water and dialysed against 50 ml distilled water for 24 h 
to remove the liberated sialic acid. 0.083 ml of the dialysed 
material (equivalent to  100 pg erythropoietin) was added to  
the incubation mixture. The experiment 2 represents data 
obtained with erythropoietin in the above manner without 
neuraminidase. I n  the experiment 4 10 pg neuraminidase 
was added to the normal incubation mixture of experiment 1. 
The tyrosine iodinase activity was again measured as the 
amount of I- incorporated in nmol x min-1 x mg-1 
System Tyrosine iodinase activity 
nmol x min-' x mg-' 
1. Enzyme 16.0 
2. Enzyme + erythropoietin 22.6 
3. Enzyme + erythropoietin (neur- 
aminidase-treated) 15.8 
4. Enzyme + neuraminidase 16.0 
v. 
0' I 1 I 1 I 
0 5 10 15 20 25 30 
Fraction no. 
Fig. 3. Elution profile of erythropoietin from DEAE-cellulose 
column. The arrow indicates the fractions pooled and 
lyophilised 
incubation system, the stirnulatory effect of the 
erythropoietin was found to be abolished. Further, 
neuraminidase a t  this concentration has no effect 
on the enzymatic iodination of tyrosine. It was also 
observed that a purer preparation of erythropoietin, 
purified as mentioned below, required a lesser quan- 
tity to produce the same stimulation in comparison 
to that obtained with a relatively impure prepara- 
tion. Step I erythropoietin (0.4 U/mg), when applied 
on DEAE-cellulose and eluted as described under 
Methods, resolved into two peaks, A and B (Fig.3). 
Table 9. Effect oj erythropoietin of two different specific 
activities on the iodination of tyrosine 
The assay of the submaxillary enzyme was same as described 
in the legend of Table4. The activity of tyrosine iodinase 
was measured as the I- incorporated in nmol x min-l x mg-l 
~ 
System Tyrosine iodinase activity 
nmol x min-' x mg-' 
Enzyme 16 
Enzyme + erythropoietin 100 p g a  23 
Enzyme + erythropoietin 50 pgb 23 
~ 
a 0.04 unit of step-I sheep erythropoietin (0.4 U/mg) was added to 
0.04 unit of purifled erythropoietin (0.8 U/mg) was added to the 
the incubation mixture. 
incubation mixture. 
The lyophilized material corresponding to peak B 
was found to be erythropoietically more potent 
(0.8 U/mg). The purified erythropoietin showed a 
lesser number of contaminating protein bands, in 
comparison to the original step I material on poly- 
acrylamide-gel electrophoresis (unpublished data). 
Using this purified erythropoietin a t  a concentration 
of half the original material, the percentage stimula- 
tion of iodination, was found to be the same as shown 
in Table 9. 
DISCUSSION 
In  order to evaluate the possible mechanism of 
action of Co2+ or vitamin B,, on the peroxidase and 
tyrosine iodinase activity of the thyroid and sub- 
maxillary glands, several possibilities were consider- 
ed: (a) the effect of Go2+ or vitamin B,, in vivo may 
be mediated a t  least partially through cobamide 
coenzyme, (b) Co2+ may be incorporated into the 
active enzyme molecule to alter its activity during 
its synthesis and (c) Co2+ or vitamin B,, in vivo may 
be responsible for the elaboration of a humoral factor 
in plasma which may have a secondary effect on the 
iodinating enzyme system. The role of cobamide 
coenzyme has already been reported earlier [l], but 
it is not the factor responsible for the cobalt effect 
presented in this communication. This results indi- 
cate that the effect is due to cobalt only. Regarding 
the second possibility, it has been observed that 
during preliminary purification of the peroxidase of 
the submaxillary gland after 6oCo administration 
and consequent isolation of its prosthetic part by 
n-butanone according to the method of Teale [20], 
Go2+ is not incorporated into the apoenzyme or 
prosthetic part of the enzyme during its synthesis 
de novo. The third possibility for a secondary humoral 
mechanism was therefore looked for. 
Results, presented in Table I, confirm the earlier 
observation that Go2+ has the ability to elicit a high 
plasma titer of erythropoietin [4]. Vitamin B,,, 
however, had no effect under identical conditions 
suggesting that vitamin B,, has no role in erythro- 
poietin production. 
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Erythropoietin has previously been extracted 
from the plasma, urine and kidney of a variety of 
species under different conditions [7,8,13-19,211. 
We have also been able to extract the erythropoietin 
from plasma or kidney of Co2+-treated mice, as evi- 
denced by its ability to  increase 6sPe incorporation 
into red blood corpuscles (Table 2). Gordon et al. [22], 
however, believe that kidney contains a renal erythro- 
poietic factor which is different from erythropoietin 
and this factor requires preincubation with plasma 
globulin to produce active hormone [23]. However, 
the material obtained from the kidney of Coa+- 
treated mice, did not require any preincubation with 
plasma protein but produced significant 6sFe incor- 
poration when injected directly into the starved rat. 
These partially purified erythropoietin prepara- 
tions from cobalt-treated animals, when adminis- 
tered, gave rise to the response (Table 3 and 4) 
almost identical to our previous observation of Co2+ 
administration [I]. The stimulation of the peroxidase 
activity by these partially purified erythropoietin 
preparations indicates that the effect of Go2+ in vivo 
was mediated, to  a large extent, through erythro- 
poietin and not due to  a cobalamine derivative. 
To support this hypothesis, the effect of sheep ery- 
thropoietin was noted on these enzyme systems, and 
the observed effect was the same as that of mouse 
erythropoietin (Table 5 and 6). 
These results in vivo were then followed by some 
experiments in vitro where the sheep erythropoietin 
was found to stimulate the tyrosine iodination 
significantly using submaxillary gland homogenate 
as the enzyme preparation. Similar stimulation was 
also obtained using soluble supernatant as the 
enzyme preparation (Fig. 2). Human urinary ery- 
thropoietin also had the same effect. This result led 
us to investigate whether the peroxidase activity 
in vitro was affected similarly by sheep erythropoietin 
preparation. It was interesting to note that both the 
guaiacol peroxidation and I,- format,ion (Table 7) 
were stimulated in the presence of the erythro- 
poietin. 
Erythropoietin is a glycoprotein containing 
sialic acid on which the biological activity depends 
and removal of sialic acid by neuraminidase absolishes 
the potency of the material [24]. Erythropoietin 
lost its stimulatory effect on iodination when pre- 
incubated with neuraminidase (Table 8). This sug- 
gests that the effect is due to  erythropoietin and not 
due to any contamination present in the erythro- 
poietin preparation. This conclusion is further 
strengthened from the data presented in Table 9, 
where 50pg of a partially purified preparation 
(0.8 U/mg) was required to produce the same stimu- 
lation as obtained with 100 pg of relatively impure 
material (0.4 U/mg). 
The role of erythropoietin on erythrocyte diffe- 
rentiation along with hemoglobin biosynthesis is 
well known [5,25-311. However, its effect on 
peroxidase or tyrosine iodinase activity has not yet 
been reported. Peroxidases are usually hemoproteins 
containing heme as a prosthetic part [32--351. It is 
therefore, very tempting to speculate that the effect 
of erythropoietin in vivo on the peroxidase is mediated 
through increased heme synthesis. As far as we know, 
every well-characterised peroxidase that has been 
tested shows both iodide peroxidase and tyrosine 
iodinase activity [32-34,361. The stimulation of 
peroxidase activity of mouse submaxillary gland by 
Co2+ through erythropoietin therefore reflects almost 
similar effects on its tyrosine iodinase activity. The 
thyroid peroxidase in the soluble supernatant frac- 
tion appears to be a non-specific peroxidase without 
having any catalysing effect on the iodination reac- 
tion. The same preparation did not catalyse the 
iodination even after an 18-h dialysis and also using 
H,O, or glucose-glucose oxidase as HzO, generator. 
The microsomal tyrosine iodinase may be different 
from this peroxidase and its inhibition by Co2+ 
in vivo may be due to  a direct interaction of Co2+ 
with the enzyme molecule [l]. However, we are now 
unable to explain why erythropoietin has opposite 
effects on the tyrosine iosinase activity of thyroid 
and submaxillary gland. 
It was known for a long time that cobalt salts 
alter thyroid function but until now, the mechan- 
ism has not been fully elucidated. From the present 
investigation, it may be suggested that the hypo- 
function of thyroid produced by Cox+ may be due 
not only to the direct action of Co2+ but also indirectly 
through the effect of erythropoietin on the thyroid 
iodinating enzyme. 
The human urinary erythropoietin was collected and 
concentrated by the Department of Physiology (University 
of the Northeast, Corrientes, Argentina) further processed 
and assayed by the Hematology Research Laboratories, 
Children Hospital of Los Angeles, under Research Grant 
HE 10880 (National Heart and Lung Institute). The authors 
would like to acknowledge the technical assistance of Mr 
H. N. Datta. 
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